- Record: found
- Abstract: not found
- Article: not found
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
Evandro De Azambuja, Andrew Holmes, Martine Piccart-Gebhart, Eileen Holmes, Serena Di Cosimo, Ramona Swaby, Michael Untch, Christian Jackisch, István Láng, Ian Smith, Frances Boyle, Binghe Xu, Carlos Barrios, Edith A Perez, Hatem A Azim, Sung-Bae Kim, Sherko Kuemmel, Chiun-Sheng Huang, Peter Vuylsteke, Ruey-Kuen Hsieh, Vera Gorbunova, Alexandru Eniu, Lydia Dreosti, Natalia Tavartkiladze, Richard D Gelber, Holger Eidtmann, José Baselga
2014-09-01
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.